Health Care & Life Sciences » Pharmaceuticals | Divi's Laboratories Ltd.

Divi's Laboratories Ltd. | Mutual Funds

Mutual Funds that own Divi's Laboratories Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
PineBridge Mauritius (GF) Ltd.
6,853,216
2.58%
1,736,364
8.42%
12/31/2017
SBI Magnum Balanced Fund - 1995
4,700,000
1.77%
0
2.85%
06/30/2018
Government Pension Fund - Global (The)
4,540,792
1.71%
2,248,866
0.01%
12/31/2017
Reliance Equity Opportunities Fund
3,000,115
1.12%
0
3.84%
08/31/2018
SBI Blue Chip Fund
2,900,551
1.09%
0
1.87%
06/30/2018
Baron Emerging Markets Fund
2,563,761
0.97%
-132,508
0.9%
06/30/2018
American Funds Small Cap World Fund
2,124,952
0.8%
0
0.1%
06/30/2018
Reliance Top 200 Fund
2,116,968
0.8%
0
2.39%
08/31/2018
HDFC Mid Cap Opportunities Fund
2,110,000
0.8%
0
1.26%
07/31/2018
GS Funds - India Equity Portfolio
1,972,875
0.74%
0
1.41%
06/30/2018

About Divi's Laboratories

View Profile
Address
1-72/23(P)/DIVIS/303
Hyderabad TS 500032
India
Employees -
Website http://www.divislabs.com
Updated 07/08/2019
Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Its product portfolio comprises of generic active pharmaceuticals ingredients; and custom system of active pharmaceuticals ingredients. The company was founded on October 12, 1990 and is headquartered in Hyderabad, India.